SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Propanc Biopharma Advances Assay Work for Planned PPC-001 Phase 1b Study

Propanc Biopharma advanced immunogenicity, pharmacokinetic and stability assay work supporting a planned first-in-human study of PPC-001 in up to 50 patients with advanced solid tumors.

PPCB

Related stories